Xeomin (incobotulinumtoxina)

pCPA File Number: 21621
Negotiation Status:
Under consideration for negotiation
Indication(s):
chronic sialorrhea associated with neurological disorders
Sponsor/Manufacturer:
Merz Therapeutics Canada
CADTH Project Number:
SR0678-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable